Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02543866 · ClinicalTrials.gov registry record · Phase 1
Fecal Microbiota Transplantation as a Strategy to Eradicate Resistant Organisms
A Phase 1 study of Infection Resistant to Drugs, sponsored by Seattle Children's Hospital.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT02543866 is a Phase 1 study of Infection Resistant to Drugs that is actively recruiting participants, run by Seattle Children's Hospital. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02543866, a Phase 1 study of Infection Resistant to Drugs, is actively recruiting participants, sponsored by Seattle Children's Hospital.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This protocol will evaluate fecal microbiota transplantation (FMT) as a strategy to eradicate intestinal colonization of extended-spectrum resistant (ESC-R) Enterobacteriaceae in pediatric patients. FMT will be performed on subjects with a history of at least one infection due to ESC-R Enterobacteriaceae. This protocol aims to determine the feasibility, safety, tolerability, and potential efficacy of FMT in pediatric patients with a history of ESC-R Enterobacteriaceae.
Conditions Studied
Interventions
- BIOLOGICAL Fecal Microbiota Transplantation
Study Locations (1)
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-02-17 |
| Est. Completion | 2026-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02543866
The ClinicalTrials.gov registry entry for NCT02543866 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infection Resistant to Drugs appearing as the primary indexed condition, and to 1 intervention - of which Fecal Microbiota Transplantation is the first listed.
NCT02543866 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT02543866 about?
NCT02543866 is a clinical study titled "Fecal Microbiota Transplantation as a Strategy to Eradicate Resistant Organisms". This protocol will evaluate fecal microbiota transplantation (FMT) as a strategy to eradicate intestinal colonization of extended-spectrum resistant (ESC-R) Enterobacteriaceae in pediatric patients. FMT will be performed on subjects with a history of at least one infection due to ESC-R Enterobacter...
What is the current status of trial NCT02543866?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2017-02-17. Estimated completion is 2026-09.
What conditions does trial NCT02543866 study?
This clinical trial studies the following conditions: Infection Resistant to Drugs.
What interventions are being tested in trial NCT02543866?
The interventions under investigation include: Fecal Microbiota Transplantation (BIOLOGICAL).
Who is sponsoring clinical trial NCT02543866?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02543866 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.